[Progress in the management of paroxysmal nocturnal hemoglobinuria by eculizumab]

Rinsho Ketsueki. 2011 Aug;52(8):633-44.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antigens, Protozoan / immunology
  • Antigens, Surface / immunology
  • Clinical Trials as Topic
  • Drug Design
  • Hemoglobinuria, Paroxysmal / diagnosis
  • Hemoglobinuria, Paroxysmal / drug therapy*
  • Hemoglobinuria, Paroxysmal / etiology
  • Hemoglobinuria, Paroxysmal / physiopathology
  • Humans
  • Molecular Targeted Therapy / trends*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antigens, Protozoan
  • Antigens, Surface
  • C5 phagosomal antigen, Paramecium multimicronucleatum
  • eculizumab